Document:

THIS
WARRANT HAS BEEN, AND THE WARRANT SHARES OF COMMON STOCK WHICH MAY BE PURCHASED PURSUANT TO THE EXERCISE OF THIS WARRANT (THE
“WARRANT SHARES”) WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION
WITH, ANY DISTRIBUTION THEREOF. NEITHER THIS WARRANT NOR THE WARRANT SHARES (TOGETHER, THE “SECURITIES”) HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS. SUCH
SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH DISPOSITION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS
OF THE ACT AND OF ANY APPLICABLE STATE SECURITIES LAWS.

 

SOUL
AND VIBE INTERACTIVE INC.

 

WARRANT
FOR THE PURCHASE OF SHARES OF COMMON STOCK

 

September
27, 2016

 

THIS
CERTIFIES THAT, for value received, Sichenzia Ross Friedman Ference LLP, a New York limited liability partnership with an address
at 61 Broadway, New York, New York 10006 (the “Holder”), is entitled to subscribe for and purchase from Soul
and Vibe Interactive Inc., a Nevada corporation with an address at 6548 South Big Cottonwood Canyon Road, Suite 200, Salt Lake
City, Utah 84121 (the “Company”), one million (1,000,000) shares (the “Warrant Shares”)
of the fully paid and nonassessable common stock, par value $0.001 per share, of the Company (the “Common Stock”),
at $0.0005 per share (the “Exercise Price”); provided that the Warrants may be exercised on a “cashless”
basis as provided herein, subject to the provisions and upon the terms and conditions hereinafter set forth.

 

This
Warrant is subject to the following terms and conditions:

 

1.TERM.
This Warrant is exercisable, in whole or in part, at any time (i) commencing on the date of this Warrant (the “Initial
Exercise Date”) and (ii) prior to the expiration of five (5) years following the date of this Warrant.

 

2.METHOD
OF EXERCISE; PAYMENT.

 

A.Cash
Exercise. The purchase rights represented by this Warrant may be exercised by the Holder, in whole or in part, from time to
time at the principal office of the Company, by delivering a completed and duly executed Notice of Exercise (attached hereto as
Exhibit A) and by the payment to the Company of an amount equal to the Exercise Price multiplied by the number of
the Warrant Shares being purchased, which amount may be paid, at the election of the Holder, by wire transfer or check payable
to the order of the Company. The person or persons in whose name(s) any certificate(s) representing Warrant Shares shall be issuable
upon exercise of this Warrant shall be deemed to have become the holder(s) of record of, and shall be treated for all purposes
as the record holder(s) of, the Warrant Shares represented thereby (and such Warrant Shares shall be deemed to have been issued)
immediately prior to the close of business on the date or dates upon which this Warrant is exercised, with the Holder having all
rights as a record holder including, but not limited to, all voting rights.

 

B.Cashless
Exercise. If at any time after six (6) months from the Initial Exercise Date, there is no effective registration statement
registering, or no current prospectus available for, the resale of the Warrant Shares on an Exercise Date, in lieu of exercising
this Warrant by payment of cash in accordance with Paragraph A of this Article 2 of this Warrant, the Holder may elect to receive
Warrant Shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant (accompanied
by the election form, attached hereto, duly executed) at the principal office of the Company together with notice of such election,
in which event the Company shall issue to the Holder hereof a number of Warrant Shares computed using the following formula:

 

	 	Y(A-B)
	X=	A

Where:

 

	 	X=	The
    number of Warrant Shares to be issued to the Holder of this Warrant.
	 	 	 
	 	Y=	The
    number of Warrant Shares purchasable under this Warrant as to which this Warrant is being exercised.
	 	 	 
	 	A=	The
    VWAP of one share of Common Stock on the Trading Day immediately preceding the date of such election.
	 	 	 
	 	B=	The
    Exercise Price (as adjusted to the date of such calculations) per share of Common Stock.

 

    	 	 	 

    	 

    

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, the OTC Bulletin Board (each a “Trading Market”), the daily volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed
or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time); (b) if the Common Stock is not then listed on a Trading Market and if prices for the Common Stock are then reported in
an over the counter market maintained by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent bid price per share of the Common Stock so reported; or (c) in all other cases, the fair
market value of a share of Common Stock shall be determined by the Company’s board of directors acting in good faith. “Trading
Day” means a day on which the Company’s principal Trading Market is open for trading.

 

C.
Stock Certificates. In the event of any exercise of the rights represented by this Warrant, certificates for the Warrant
Shares of Common Stock so purchased shall be delivered to the Holder within three (3) business days after said exercise and, unless
this Warrant has been fully exercised or has expired, a new Warrant representing the Warrant Shares with respect to which this
Warrant shall not have been exercised shall also be issued to the Holder within such time provided a copy of any other Warrant
issued to the Holder is delivered to the Company prior to the issuance of a new Warrant. If the Company fails to deliver the Warrant
Shares of Common Stock so purchased to the Holder pursuant to this Paragraph C of this Article 2 of this Warrant, the Company
shall pay the Holder an additional amount of one thousand dollars ($1,000) per calendar day for each late day of delivery. The
Company acknowledges that it would be extremely difficult or impracticable to determine the Holder’s actual damages and
costs resulting from the delay in providing an opinion or approval for said sale of securities and the inclusion herein of any
such additional amounts are the agreed upon liquidated damages representing a reasonable estimate of those damages and costs and
do not constitute a penalty.

 

D.
Cooperation. The Company shall provide to the Holder all information requested and fully cooperate with the Holder
with respect to the exercise of this Warrant.

 

3.STOCK
FULLY PAID; RESERVATION OF WARRANT SHARES; CERTAIN EXERCISE LIMITS. All of the Warrant Shares issuable upon the exercise of
the rights represented by this Warrant will, upon issuance and receipt of the Exercise Price thereof, be fully paid and nonassessable,
and free from all preemptive rights, rights of first refusal or first offer, taxes, liens and charges with respect to the issuance
thereof. During the period within which the rights represented by this Warrant may be exercised, the Company shall at all times
have authorized and reserved for issuance sufficient Warrant Shares of its Common Stock to provide for the exercise of the rights
represented by this Warrant.

 

Notwithstanding
anything herein to the contrary, the Holder shall not be entitled to exercise any portion of this Warrant (or acquire any other
securities of the Company) which would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the
outstanding shares of Common Stock of the Company at the time of conversion, provided, however, that the limitations on exercise
may be waived by the Holder upon, at the election of the Holder, not less than 61 days’ prior notice to the Company, and
the provisions of the exercise limitation shall continue to apply until such 61st day (or such later date, as determined by the
Holder, as may be specified in such notice of waiver).

 

    	 	2	 

    	 

    

 

4.ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. Subject to the provisions of Article 1 hereof, the number and kind of Warrant
Shares purchasable upon the exercise of this Warrant and the Exercise Price thereof shall be subject to adjustment from time to
time upon the occurrence of certain events, as follows:

 

A.Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of such shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of such shares or (iv) issues by reclassification
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such
event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and
the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 4(A) shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or re classification.

 

B.Intentionally
omitted.

 

C.Subsequent
Rights Offerings. If the Company, at any time while this Warrant is outstanding, shall issue rights, options or warrants to
all holders of Common Stock (and not to the Holder) entitling them to subscribe for or purchase Warrant Shares of Common Stock
at a price per share less than the VWAP on the record date mentioned below, then the Exercise Price shall be multiplied by a fraction,
of which the denominator shall be the number of Warrant Shares of the Common Stock outstanding on the date of issuance of such
rights, options or warrants plus the number of additional Warrant Shares of Common Stock offered for subscription or purchase,
and of which the numerator shall be the number of Warrant Shares of the Common Stock outstanding on the date of issuance of such
rights, options or warrants plus the number of Warrant Shares which the aggregate offering price of the total number of Warrant
Shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise of such rights, options
or warrants) would purchase at such VWAP. Such adjustment shall be made whenever such rights, options or warrants are issued,
and shall become effective immediately after the record date for the determination of stockholders entitled to receive such rights,
options or warrants.

 

D.Pro
Rata Distributions. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common
Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants
to subscribe for or purchase any security other than the Common Stock, then in each such case the Exercise Price shall be adjusted
by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders entitled
to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned
above, and of which the numerator shall be such VWAP on such record date less the then per share fair market value at such record
date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one outstanding
share of the Common Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be described
in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall
become effective immediately after the record date mentioned above.

 

    	 	3	 

    	 

    

 

E.Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets
in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares thereof for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person
or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon
such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder, the number of
shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any
additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply
to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and
the other Transaction Documents in accordance with the provisions of this Section 4(E) pursuant to written agreements in form
and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Warrant Shares
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

F.Calculations.
All calculations under this Section 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

G.Notice
to Holder.

 

i.Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 4, the Company shall
promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of
the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become
effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange
their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K or issue a press release disclosing
such material non-public information. The Holder shall remain entitled to exercise this Warrant during the period commencing on
the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth
herein.

 

    	 	4	 

    	 

    

 

5.FRACTIONAL
WARRANT SHARES. The Company shall not be required to issue fractional shares of Common Stock
or other capital stock of the Company upon the exercise of this Warrant. If any fraction of a share of Common Stock would be issuable
on the exercise of this Warrant (or specified portions thereof), the Company shall round up the number of such shares to the nearest
whole.

 

6.REPRESENTATIONS
AND WARRANTIES OF THE COMPANY. The Company represents and warrants to the Holder as follows:

 

A.This
Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable
with its terms;

 

B.The
Warrant Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms
hereof, will be validly issued, fully paid and nonassessable; and

 

C.The
execution and delivery of this Warrant are not, and the issuance of the Warrant Shares upon exercise of this Warrant in accordance
with the terms hereof will not be, inconsistent with the Company’s Articles of Incorporation or Bylaws, as amended.

 

7.BROKER.
The Company has not had any dealings with respect to the transactions set forth in this Warrant with any business broker, firm
or salesman, or any person or corporation, investment banker or financial advisor who is or shall be entitled to any broker’s
or finder’s fee or any other commission or similar fee with respect to the transactions set forth in this Warrant. The Company
represents that it has not dealt with any such person, firm or corporation with respect to the transactions set forth in this
Warrant and agrees to indemnify and hold harmless the Holder from and against any and all claims for brokerage commissions by
any person, firm or corporation on the basis of any act or statement alleged to have been made by the Company or its affiliates
or agents.

 

8.RIGHTS
OF STOCKHOLDERS. No holder of this Warrant shall be entitled, as a warrant holder, to vote or receive dividends or be deemed
the holder of Common Stock or any other securities of the Company which may at any time be issuable on the exercise hereof for
any purpose, nor shall anything contained herein be construed to confer upon the Holder of this Warrant, as such, any of the rights
of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders
at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of
stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of
meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Warrant
Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein.

 

9.
REGISTRATION.

 

A.If
the Company shall at any time seek to register or qualify any of its Common Stock or the securities holdings of any of its controlling
shareholders, on each such occasion it shall, without cost or expense, include all of the Holder’s Warrant Shares in such
registration or qualification. The Company shall keep the registration statement effective until such time as the Holder has sold
its Warrant Shares or the Warrant Shares are eligible to be transferred without restriction pursuant to the provisions of Rule
144 which was promulgated by the Securities and Exchange Commission pursuant to §4(1) of the Securities Act of 1933, as amended
(“Rule 144”). The Company agrees to provide an opinion of counsel with respect to any sales of the Warrant
Shares by the Holder if such sale is permissible under Rule 144.

 

    	 	5	 

    	 

    

 

B.All
expenses in connection with preparing and filing any registration statement under Paragraph A of this Article 9 of this Warrant
shall be borne in full by the Company; provided, however, that the Holder shall pay any and all underwriting commissions and expenses
and the fees and expenses of any legal counsel selected by the Holder to represent it with respect to the sale of the Securities.

 

10.
OPINIONS. The Company shall, at its cost, provide the appropriate opinion letters to be issued by the Company’s
counsel in compliance with the provisions of Rule 144 with respect to the transfer or sale of the Warrant Shares, if such transfer
or sale is permissible under Rule 144. Furthermore, the Company shall notify counsel designated by the Holder that it is authorized
to issue said opinion letters. If the Company fails to timely provide or approve legal opinions and deliver stock certificates
pursuant to this Article 10 of this Warrant within three (3) business days after the exercise of this Warrant, the Company agrees
to pay the Holder an additional amount of five hundred dollars ($250) per day for each day that said opinions or approvals or
delivery of stock certificates are delayed. The Company acknowledges that it would be extremely difficult or impracticable to
determine the Holder’s actual damages and costs resulting from the delay in providing opinions or approvals for said sale(s)
of securities and the inclusion herein of any such additional amounts are the agreed upon liquidated damages representing a reasonable
estimate of those damages and costs and do not constitute a penalty.

 

11.
IRREVOCABLE WARRANT. The Company acknowledges and agrees that this Warrant has been duly authorized by all necessary action
by its Board of Directors, and has been irrevocably issued. Accordingly, the Company further agrees that it shall not challenge
or take any action with respect to the validity of this Warrant on any basis and agrees to reimburse the Holder for all legal
fees and costs incurred by the Holder with respect to any challenge to the validity of this Warrant by the Company.

 

12.MISCELLANEOUS.

 

A.Headings.
Headings contained in this Warrant are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Warrant.

 

B.Enforceability.
If any provision which is contained in this Warrant should, for any reason, be held to be invalid or unenforceable in any respect
under the laws of any jurisdiction, such invalidity or unenforceability shall not affect any other provision of this Warrant and
this Warrant shall be construed as if such invalid or unenforceable provision had not been contained herein.

 

C.Notices.
Any notice or other communication required or permitted hereunder shall be sufficiently given if sent by (i) mail by (a) certified
mail, postage prepaid, return receipt requested and (b) first class mail, postage prepaid (ii) overnight delivery with confirmation
of delivery or (iii) facsimile transmission with an original mailed by first class mail, postage prepaid, addressed as follows:

 

	To
    the Holder:	Sichenzia
    Ross Friedman Ference LLP
	 	61
    Broadway, 32nd Floor
	 	New
    York, New York 10006
	 	Attn:
    Richard A. Friedman, Esq.
	 	Fax
    No.: (212) 930-9725
	 	 
	To
    the Company:	Soul
    and Vibe Interactive, Inc.
	 	6548
    South Big Cottonwood Canyon Road, Suite 200
	 	Salt
    Lake City, Utah 84121
	 	Attn:
    Peter Anthony Chiodo, President & CEO
	 	Fax
    No.: 763-645-5364

 

or
in each case to such other address and facsimile number as shall have last been furnished by like notice. If all of the methods
of notice set forth in this Paragraph C of this Article 12 of this Warrant are impossible for any reason, notice shall be in writing
and personally delivered to the aforesaid addresses. Each notice or communication shall be deemed to have been given as of the
date so mailed or delivered as the case may be; provided, however, that any notice sent by facsimile shall be deemed to have been
given as of the date so sent if a copy thereof is also mailed by first class mail on the date sent by facsimile. If the date of
mailing is not the same as the date of sending by facsimile, then the date of mailing by first class mail shall be deemed to be
the date upon which notice is given; provided further, however, that any notice sent by overnight delivery shall be deemed to
have been given as of the date of delivery.

 

    	 	6	 

    	 

    

 

D.Governing
Law; Disputes. This Warrant shall in all respects be construed, governed, applied and enforced in accordance with the laws
of the State of New York applicable to contracts made and to be performed therein, without giving effect to the principles of
conflicts of law. The parties hereby consent to and irrevocably and exclusively submit to personal jurisdiction over each of them
by the Courts of the State of New York in any action or proceeding, irrevocably waive trial by jury and personal service of any
and all process and specifically consent that in any such action or proceeding, any service of process may be effectuated upon
any of them by certified mail, return receipt requested, in accordance with Paragraph C of this Article 12 of this Warrant.

 

F.
Construction. Each of the parties hereto hereby further acknowledges and agrees that this Warrant shall not be construed
more strictly against any party responsible for its drafting regardless of any presumption or rule requiring construction against
the party whose attorney drafted this agreement.

 

G.
Entire Warrant. This Warrant and all documents and instruments referred to herein (i) constitute the entire agreement
and supersede all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter
hereof and thereof, and (ii) are not intended to confer upon any person other than the parties hereto any rights or remedies hereunder.
Each party hereto agrees that, except for the representations and warranties contained in this Warrant, neither party makes any
other representations or warranties, and each hereby disclaims any other representations and warranties made by itself or any
of its officers, directors, employees, agents, financial and legal advisors or other representatives, with respect to the execution
and delivery of this Warrant or the transactions contemplated hereby, notwithstanding the delivery or disclosure of any documentation
or other information with respect to any one or more of the foregoing.

 

H.
Third Party Beneficiaries. This Warrant and all documents and instruments referred to herein are not intended to confer
upon any person (other than the parties hereto and their respective heirs, executors, administrators, personal representatives,
successors and assigns) any legal or equitable right or remedy of any nature whatsoever pursuant to or by reason of this Warrant.

 

I.
Further Assurances. The parties agree to execute any and all such other further instruments and documents, and to take
any and all such further actions which are reasonably required to effectuate this Warrant and the intents and purposes hereof.

 

J.Binding
Effect. This Warrant shall be binding upon and inure to the benefit of the parties hereto and their heirs, executors, administrators,
personal representatives, successors and assigns.

 

K.
Non-Waiver. Except as otherwise expressly provided herein, no waiver of any covenant, condition, or provision of this
Warrant shall be deemed to have been made unless expressly in writing and signed by the party against whom such waiver is charged;
and (i) the failure of any party to insist in any one or more cases upon the performance of any of the provisions, covenants or
conditions of this Warrant or to exercise any option herein contained shall not be construed as a waiver or relinquishment for
the future of any such provisions, covenants or conditions, (ii) the acceptance of performance of anything required by this Warrant
to be performed with knowledge of the breach or failure of a covenant, condition or provision hereof shall not be deemed a waiver
of such breach or failure, and (iii) no waiver by any party of one breach by another party shall be construed as a waiver of any
other or subsequent breach.

 

L.
Counterparts. This Warrant may be executed simultaneously in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument.

 

M.No
Assignment. The parties hereby agree that the obligations under this Warrant shall not be transferred or assigned to any third
parties without the prior written consent of each party to this Warrant.

 

    	 	7	 

    	 

    

 

N.
Facsimile Signatures. Any signature which is delivered via facsimile shall be deemed to be an original and have the
same force and effect as if such facsimile signature were the original thereof.

 

O.
Modifications. This Warrant may not be changed, modified, extended, terminated or discharged orally, except by a written
agreement specifically referring to this Warrant which is signed by the Holder and the Company.

 

P.
Severability. The provisions of this Warrant shall be deemed separable. Therefore, if any part of this Warrant is rendered
void, invalid or unenforceable, such rendering shall not affect the validity or enforceability of the remainder of this Warrant;
provided, however, that if the part or parts which are void, invalid or unenforceable as aforesaid shall substantially impair
the value of this whole Warrant to any party, that party may cancel, and terminate this Warrant by giving written notice to the
other party.

 

    	 	8	 

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer.

 

Issued
this 27th day of September, 2016.

	 	Soul and Vibe Interactive Inc.
	 	 	 
	 	By:	/s/ Peter Anthony Chiodo
	 	 	Peter Anthony Chiodo, President & CEO

  

 

	

Acknowledged
and Accepted:

 

Sichenzia
Ross Friedman Ference LLP

	 	 
	 	 	 
	 	 	 
	By: Richard Friedman, Partner	 	 

 

    	 	9	 

    	 

    

 

EXHIBIT
A

 

FORM
OF EXERCISE NOTICE

[To
be executed only upon exercise of Warrant]

 

To
SOUL AND VIBE INTERACTIVE INC.:

 

The
undersigned registered holder of the within Warrant hereby irrevocably exercises the Warrant pursuant to Section 2 of the Warrant
with respect to ________________________ Warrant Shares, at an exercise price per share of $[ ], and requests that the certificates
for such Warrant Shares be issued in the name of, and delivered to:

 

______________________________________

______________________________________

______________________________________

______________________________________

 

The
undersigned is hereby making payment for the Warrant Shares in the following manner: [check one]

 

[  ]by
cash in accordance with Section 2(A) of the Warrant

 

[  ]via
cashless exercise in accordance with Section 2(B) of the Warrant in the following manner:

 

______________________________________________________________________________

______________________________________________________________________________

______________________________________________________________________________

 

The
undersigned hereby represents and warrants that it is, and has been since its acquisition of the Warrant, the record and beneficial
owner of the Warrant.

 

Dated:
_______________

 

________________________________________

Print
or Type Name

 

________________________________________

(Signature
must conform in all respects to name of holder as specified on the face of Warrant)

 

________________________________________

(Street
Address)

 

________________________________________

(City)                    (State)                    (Zip
Code)

 

    	 	10Exhibit

EMPLOYMENT AGREEMENT 
KATHERINE HARPER
EMPLOYMENT AGREEMENT (the “Agreement”) dated as of September 23, 2016 by and between AgroFresh Solutions, Inc. (the “Company”) and Katherine Harper (“Executive”).
NOW THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties agree as follows:
1.Term of Employment. Subject to the provisions of Section 7 of this Agreement, Executive shall be employed by the Company for a period commencing on October 3, 2016, or such other date as may be mutually agreed upon by the Company and Executive (the “Effective Date”), and ending on the day before the third anniversary of the Effective Date (the “Employment Term”) on the terms and subject to the conditions set forth in this Agreement; provided, however, that commencing with the third anniversary of the Effective Date and on each anniversary thereafter (each an “Extension Date”), the Employment Term shall be automatically extended for an additional one-year period, unless the Company or Executive provides the other party hereto 30 days prior written notice before the next Extension Date that the Employment Term shall not be so extended.
2.Position.
a.During the Employment Term, Executive shall serve as Chief Financial Officer of the Company and will report to the Chief Executive Officer of the Company. In such position, Executive shall have the duties and authority commensurate with the position as shall be determined from time to time by the Chief Executive Officer of the Company or the Board of Directors of the Company (the “Board”). 
b.During the Employment Term, Executive will devote her full business time and best efforts, in accordance with legal and regulatory requirements, to the performance of Executive’s duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise, including without limitation service on any board of directors or trustees of any business corporation or charitable organization, without the prior written consent of the Board.
3.Base Salary and Signing Bonus. 
a.During the Employment Term, the Company shall pay Executive a base salary (the “Base Salary”) at the annual rate of not less than $450,000, payable in regular installments in accordance with the Company’s usual payment practices.  Executive shall be entitled to annual reviews and increases in Executive’s Base Salary, if any, as may be determined in the sole discretion of the Compensation Committee. The Executive’s Base Salary may not be decreased at any time during the Employment Term.  
b.Executive shall receive a one-time signing bonus in the gross amount of $50,000, payable ninety (90) days following the Effective Date, provided she is in the employ of the Company on the date that payment is due.
4.Incentive Compensation. 
a.With respect to each full fiscal year during the Employment Term, Executive shall be eligible to earn an annual bonus award (an “Annual Bonus”) payable in cash with a target amount equal to 70% of Executive’s Base Salary (the “Target”), based upon the achievement of performance objectives established by the Compensation Committee each year.  For calendar year 2016, the Annual Bonus shall be prorated, based upon the portion of the year that Executive is employed by the Company.  The “fiscal year” during the Employment Term shall be equal to the calendar year unless otherwise established by the Board in consultation with Executive. The performance objectives for payment of the Annual Bonus shall be established in writing by the Compensation Committee, on or before the end of the third month of the applicable fiscal year and shall include performance metrics which enable the Executive to earn up to two times the Target in the event certain performance conditions are met. Any Annual Bonus earned for any calendar year shall be paid within the first 2 1⁄2 months of the immediately following calendar year.  
b.The Company has adopted an equity incentive plan reserving 2,750,000 shares of common stock of the Company (the “Equity Plan”).  As soon as reasonably practicable following the Effective Date (the “Grant Date”), the Company shall grant the Executive awards (collectively, the “Equity Award”) under the Equity Plan, consisting of (i) restricted stock (“Restricted Stock”) having a value of $400,000 based on the Fair Market Value (as defined in the Equity Plan) of the Company’s common stock on the Grant Date and (ii) nonqualified stock options (“Options”) with respect to that number of shares of the Company’s common stock equal to $400,000 divided by the Fair Market Value of the Company’s common stock on the Grant Date, with an exercise price per share equal to such Fair Market Value. The vesting schedule for the Restricted Stock and Options subject to the Equity Award shall be as follows:  100% of the Options and the Restricted Stock subject to the Equity Award shall vest over three (3) years in three equal installments on each anniversary of the Grant Date, beginning on the first anniversary of the Grant Date; provided that Executive’s employment with the Company continues through and on the applicable vesting date. The Restricted Stock and Options subject to the Equity Award shall be subject to such other terms as set forth in the applicable grant agreements and in the underlying Equity Plan.  
c.The Compensation Committee will establish a long-term incentive plan for executives and other key employees in 2017 (the “2017 LTI Plan”). The Executive shall be entitled to receive equity awards having a total target value equal to 150% of the Base Salary as of the date of grant pursuant to the 2017 LTI Plan, allocated among stock options, shares of restricted stock subject to time-based vesting, and shares of restricted stock subject to performance-based vesting, based on the overall terms of and subject to the conditions to be set forth in the 2017 LTI Plan, as determined by the Compensation Committee. In successive years during the Employment Term, the Executive shall be eligible for additional grants of restricted stock, stock options and any other forms of incentive compensation during the Employment Term, with the aggregate grant date target value of each of such grants to be 150% of the Base Salary as of the date of grant. For purposes hereof, the “total target value” of any equity award shall be calculated as the Fair Market Value (as defined in the Equity Plan) of the Company’s common stock on the date of grant multiplied by the number of shares of stock subject to the equity award (including, in the case of stock options, the number of shares of stock issuable upon exercise of such options). 
d.The Company may (i) cause the cancellation of the Equity Award or any additional grants of restricted stock, options and any other forms of incentive compensation during the Employment Term, (ii) require reimbursement of the Equity Award or any additional grants of restricted stock, options and any other forms of incentive compensation during the Employment Term, and (iii) effect any other right of recoupment of equity or other compensation provided under this Agreement or otherwise, in all respects as to subclauses (i), (ii) and (iii) hereof, as required by and in accordance with applicable law.
5.Employee Benefits.
a.General. During the Employment Term, Executive shall be entitled to participate in the Company’s employee benefit plans, as amended from time to time, as in effect from time to time, including disability benefits (collectively “Employee Benefits”), on the same basis as those benefits are generally made available to other senior executives of the Company.
b.Life Insurance. During the Employment Term, the Company will provide Executive life insurance covering at least four times her Base Salary. 
c.Tax Preparation and Financial Planning Expenses.  During the Employment Term, the Company shall reimburse the Executive up to $15,000 per calendar year for annual tax preparation and financial planning expenses.
6.Business Expenses. During the Employment Term, reasonable business expenses incurred by Executive in the performance of Executive’s duties hereunder shall be reimbursed by the Company in accordance with Company policies.
7.Termination. The Employment Term and Executive’s employment hereunder may be terminated by either party at any time and for any reason; provided that Executive will be required to give the Company at least 60 days advance written notice of any resignation of Executive’s employment, subject to and in accordance with the provisions of this Section 7.  Notwithstanding any other provision of this Agreement, subject to Sections 8, 9, 10, 11(f), 11(j), 11(m) and 11(o), the provisions of this Section 7 shall exclusively govern Executive’s and the Company’s rights and obligations related to termination of this Agreement and the rights and remedies upon termination of employment with the Company and its affiliates.
a.  By the Company For Cause or Resignation by the Executive without Good Reason.
(i)    The Employment Term and Executive’s employment hereunder may be terminated by the Company for “Cause” (as defined below) and shall terminate automatically upon Executive’s resignation without “Good Reason” (as defined below), provided that Executive will be required to give the Company at least 60 days advance written notice of any such resignation, and provided further that the Company may elect to waive such notice period and to pay Executive in lieu of such notice.

(i)For purposes of this Agreement “Cause” shall mean (A) Executive’s continued failure to substantially perform Executive’s duties hereunder (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to Executive of such failure; provided that it is understood that this clause (A) shall not permit the Company to terminate Executive’s employment for Cause because of dissatisfaction with the quality of services provided by or disagreement with the actions taken by Executive in the good faith performance of Executive’s duties to the Company, (B) theft or embezzlement of Company property, (C) Executive’s conviction of or plea of guilty or no contest to (x) a felony or (y) a crime involving moral turpitude, (D) Executive’s willful malfeasance or willful misconduct in connection with Executive’s duties hereunder or any act or omission taken in bad faith which is materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries or affiliates, or (E) Executive’s material breach of any provisions of this Agreement.
(ii)If Executive’s employment is terminated by the Company for Cause, or if Executive resigns without Good Reason, Executive shall be entitled to receive, within 30 days following such termination with respect to (A)-(C) below, and at such time, if any, as the Employee Benefits under (D) below become due in accordance with the applicable terms thereof:
(A)the Base Salary earned ratably through the date of termination, to the extent not already paid;
(B)any Annual Bonus earned but unpaid as of the date of termination for any previously completed fiscal year;
(C)reimbursement for any unreimbursed business expenses properly incurred by Executive in accordance with the Company policy prior to the date of Executive’s termination; and
(D)such vested Employee Benefits, if any, as to which Executive may be entitled under the employee benefit plans of the Company as described in Section 5(a) (including, without limitation, any retirement benefits, medical, life insurance or disability benefits, accrued but unpaid vacation or other benefits Executive is entitled to pursuant to the terms of the applicable plans then in effect (the amounts described in clauses (A) through (D) hereof being referred to as the “Accrued Obligations”).
Following such termination of Executive’s employment by the Company for Cause or resignation by Executive without Good Reason, except as set forth in this Section 7(a)(iii), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment.  Notwithstanding the foregoing, nothing in this Section 7(a) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
b.    Disability or Death.
(i)    The Employment Term and Executive’s employment hereunder shall terminate upon Executive’s death and may be terminated by the Company if Executive becomes physically or mentally incapacitated and is therefore unable for a period of six (6) consecutive months or for an aggregate of nine (9) months in any twenty-four (24) consecutive month period to perform Executive’s duties (such incapacity is hereinafter referred to as “Disability”); provided that a termination on the basis of a Disability must occur within 90 days of the date when Executive is subject to termination due to Disability. Any question as to the existence of the Disability of Executive as to which Executive and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to Executive and the Company. If Executive and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third physician and it shall be the responsibility of such third physician to make such determination in writing. The determination of Disability made in writing to the Company and Executive shall be final and conclusive for all purposes of the Agreement.
(ii)    Upon termination of Executive’s employment hereunder for either Disability or death, Executive or Executive’s estate (as the case may be) shall be entitled to receive, at the times set forth in Section 7(a)(iii) hereof, the Accrued Obligations.  
Following Executive’s termination of employment due to death or Disability, except as set forth in this Section 7(b)(ii), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment.  Notwithstanding the foregoing, nothing in this Section 7(b) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
c.      By the Company Without Cause or Resignation by Executive for Good Reason.
(i) The Employment Term and Executive’s employment hereunder may be terminated by the Company without Cause or by Executive’s resignation for Good Reason.
(ii) If Executive’s employment is terminated by the Company without Cause (other than by reason of death or Disability) or by Executive’s resignation for Good Reason, and subject to the conditions described below, Executive shall be entitled to receive:
(A)At the times set forth in Section 7(a)(iii) hereof, the Accrued Obligations;
(B)payment of an amount equal to 1.5 times the Base Salary in effect at the time of termination (except that in the event of termination within twelve (12) months of the Effective Date, such payment amount shall be equal to 1.0 times the Base Salary then in effect), payable, in equal installments in accordance with regular payroll procedures established by the Company, over a twelve month period beginning with the first payroll date that occurs on or after the sixtieth (60th) day following the date on which the Employment Term and Executive’s employment hereunder terminated; and
(C)if Executive elects continued coverage for herself or her eligible dependents under any of the Company’s health plans pursuant to Section 4980B of the Internal Revenue Code of 1986, as amended (the “Code”) or any comparable law (“COBRA”), for each month during which such coverage is in effect (but not more than twelve (12) months), an amount equal to the difference between the premium paid for such COBRA coverage and the premium charged by the Company to an active employee for comparable coverage, which monthly amount shall be payable over a 12 month period (or shorter period to the extent the Executive elects COBRA coverage for less than 12 months), beginning with the first payroll date that occurs on or after the sixtieth (60th) day following the date on which the Employment Term and Executive’s employment hereunder terminated.  
(iii)    For purposes of this Agreement, “Good Reason” shall mean (A) a failure of the Company to pay or cause to be paid Executive’s Base Salary or Annual Bonus (if any) when due, (B) a reduction in Executive’s Base Salary or the Target for her Annual Bonus opportunity described in Section 4 herein, (C) a relocation of Executive’s primary work location of more than 50 miles from the work location on the Effective Date, without written consent of Executive, or (D) a material reduction or modification in Executive’s duties, responsibilities or reporting structure as described in Section 2(a) of this Agreement; provided that none of these events shall constitute Good Reason unless (1) the Executive provides the Company with written notice of the existence of such condition within 30 days after the initial existence of the condition, (2) the Company fails to remedy the condition within 30 days after its receipt of such notice and (3) the Executive resigns within 30 days after the expiration of such 30-day remedy period.
The payments and benefits described in subparagraphs 7(c)(ii)(B) - (C) above shall be subject to and conditioned upon (1) Executive’s execution and delivery of a valid and effective general release and waiver in such form as reasonably provided by the Company, containing standard and customary terms not inconsistent with the terms of this Agreement, to effectuate a valid release of claims (exempting any claims to enforce Executive’s rights under this Agreement) that becomes irrevocable within sixty (60) days of the date on which the Employment Term and Executive’s employment hereunder terminates; and (2) Executive’s continued compliance with her obligations under Sections 8 and 9 of this Agreement.  Following Executive’s termination of employment by the Company without Cause (other than by reason of Executive’s death or Disability) or by Executive’s resignation for Good Reason, except as set forth in Section 7(c)(ii), and subject to Section 7(e) below, Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment.  Notwithstanding the foregoing, nothing in this Section 7(c) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
d.  Election Not to Extend the Employment Term. In the event either party elects not to extend the Employment Term by providing thirty (30) days’ written notice prior to the end of the then-current term pursuant to Section 1, unless Executive’s employment is earlier terminated pursuant to paragraphs (a), (b) or (c) of this Section 7, Executive’s termination of employment hereunder (whether or not Executive continues as an employee of the Company thereafter) shall be deemed to occur on the close of business on the day immediately preceding the next scheduled Extension Date. If Executive’s employment is terminated following Executive’s election not to extend the Employment Term, Executive shall be entitled to receive the Accrued Obligations. If the Company elects not to extend the Employment Term, Executive shall be entitled to receive the severance payments and benefits set forth in Section 7(c). The payments and benefits described in this Section 7(d) shall be subject to and conditioned upon (1) Executive’s execution and delivery of a valid and effective general release and waiver, in such form as reasonably provided by the Company to effectuate a valid release of claims (exempting any claims to enforce Executive’s rights under this Agreement) that becomes irrevocable within sixty (60) days of the date on which the Employment Term and Executive’s employment hereunder terminates; and (2) Executive’s continued compliance with her obligations under Sections 8 and 9 of this Agreement. Following such termination of Executive’s employment hereunder as a result of either party’s election not to extend the Employment Term, except as set forth in this Section 7(d), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment. Notwithstanding the foregoing, nothing in this Section 7(d) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including, but not limited to, any retirement plans.
e. Notice of Termination. Any purported termination of employment by the Company or by Executive (other than due to Executive’s death) shall be communicated by written Notice of Termination to the other party hereto in accordance with Section 11(g) hereof. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated.
f. Continuing Rights Under Equity Plan.  Notwithstanding anything herein to the contrary, upon a termination of employment, Executive’s rights and obligations post-termination with respect to awards made under the Equity Plan shall be determined in accordance with the Equity Plan and Section 4 hereof.
g. Parachute Payments.  Notwithstanding any other provision of this Agreement to the contrary, to the extent that any payment or distribution of any type to or for the Executive by the Company (or by any affiliate of the Company, any person or entity who acquires ownership or effective control of the Company or ownership of a substantial portion of the Company’s assets (within the meaning of Section 280G of the Code and the regulations thereunder)), or any affiliate of such person or entity, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Total Payments”), is or will be subject to the excise tax imposed under Section 4999 of the Code (the “Excise Tax”), then the Total Payments shall be reduced (but not below zero) if and to the extent that a reduction in the Total Payments would result in the Executive’s retaining a larger amount, on an after-tax basis (taking into account federal, state and local income taxes and the Excise Tax), than if the Executive received the entire amount of such Total Payments.  The determination of whether the Total Payments shall be reduced and the amount of such reduction shall be determined by an accounting firm selected by the Executive and the Company (which accounting firm’s fees shall be paid for by the Company), and shall be final and binding upon the Executive and the Company.  The accounting firm’s decision as to which of the Total Payments are to be reduced, if any, shall be made (A) only from the Total Payments that the accounting firm determines reasonably may be characterized as “parachute payments” under Section 280G of the Code; (B) only from the Total Payments that are required to be made in cash, (C) only with respect to any amounts that are not payable pursuant to a “nonqualified deferred compensation plan” subject to Section 409A of the Code, until those payments have been reduced to zero, and (D) in reverse chronological order, to the extent that any of the Total Payments subject to reduction are made over time (e.g., in installments).  In no event, however, shall any of the Total Payments be reduced if and to the extent such reduction would cause a violation of Section 409A of the Code or other applicable law.  
8.Non-Competition.
a.  Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and accordingly agrees as follows:
(i)    During her employment with the Company and for a period of 18 months following the date Executive ceases to be employed by the Company (the “Restricted Period”), Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, company, business entity or other organization engaged in a Competitive Business (as defined below), directly or indirectly, solicit or assist in soliciting any business related to a Competitive Business from any client or prospective client of the Company or any of its affiliates.
(ii)     During the Restricted Period and within the Continents of North America, South America, Africa, Europe, Asia, and Australia (the “Restricted Territory”), which is the territory in which the Company does business and the Executive will provide services to the Company, Executive will not directly or indirectly:
(A)engage in a Competitive Business;
(B)enter the employ of, or render any services to, any person or entity (or any division of any person or entity) who or which engages in a Competitive Business;
(C)acquire a financial interest in, or otherwise become actively involved with, any Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant; or
(D)interfere with, or attempt to interfere with, business relationships (whether formed before, on or after the date of this Agreement) between the Company or any of its affiliates and customers, clients, suppliers, partners, members or investors of the Company or any of its affiliates.
(iii) For purposes of this Agreement, “Competitive Business” means the development, manufacture, license, sale or provision of agricultural products or services and any other business in which the Company or any of its affiliates engaged while the Executive was employed by the Company.
(iv)  Notwithstanding anything to the contrary in this Agreement, Executive may, directly or indirectly, own, solely as a passive investment, securities of any person engaged in a Competitive Business which is publicly traded on a national or regional stock exchange or on the over-the-counter market if Executive (i) is not a controlling person of, or a member of a Group which controls, such person and (ii) does not, directly or indirectly, own 5% or more of any class of securities of such person.
(v)   During the Restricted Period, Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, company, business entity or other organization whatsoever, directly or indirectly:
(A)solicit or encourage any employee of the Company or any of its affiliates to leave the employment of the Company or such affiliate; or
(B)hire any employee who was employed by the Company or any of its affiliates as of the date of Executive’s termination of employment with the Company or thereafter, or who left the employment of the Company or any of its affiliates coincident with, or within six months prior to or after, the termination of Executive’s employment with the Company.
(vi)  During the Restricted Period, Executive will not, directly or indirectly, solicit or encourage to cease to work with the Company any individual consultant then under contract with the Company or any of its affiliates.
b. The parties agree that the Restricted Period shall be tolled during the pendency of any litigation or arbitration relating to the interpretation or enforcement of the covenants set forth in this Section 8. 
c.  It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in this Section 8 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein.
9.Confidentiality; Inventions.
a. Confidentiality. Commencing on the date hereof and continuing during the Employment Term and thereafter, Executive will not disclose or use for Executive’s own benefit or purposes or the benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise other than the Company, any trade secrets, or other confidential information or data of the Company (or any of its affiliates) relating to the Company’s (or any such affiliate’s) customers, development programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, manufacturing processes, financing methods, plans, or the business and affairs of the Company (or any such affiliate) generally; provided that the foregoing shall not apply to information which is not unique to the Company or which is generally known to the industry or the public other than as a result of Executive’s breach of this covenant. Except as required by law, Executive will not disclose to anyone, other than her immediate family, legal or financial advisors or any subsequent employer, the contents of this Agreement. Executive agrees that upon termination of Executive’s employment with the Company for any reason, she will return to the Company immediately all memoranda, books, papers, plans, information, letters and other data, and all copies thereof or therefrom, in any way relating to the business of the Company and its affiliates, except that she may retain personal notes, notebooks and diaries and personally owned books, reference material or information of a similar nature, that do not contain confidential information of the type described in the preceding sentence of this section. Executive further agrees that she will not retain or use for Executive’s account at any time any trade names, trademark or other proprietary business designation used or owned in connection with the business of the Company and its affiliates.
b. Ownership of Inventions. Executive agrees that Executive will promptly make full written disclosure to the Company, and hereby assigns to the Company, or its designee, all of Executive’s right, title, and interest in and to any and all creations, inventions or developments, whether or not patentable, which Executive may solely or jointly conceive or develop or reduce to practice, during the period of time Executive is in the employ of the Company (collectively referred to as “the Company Inventions”), other than (and the Company Inventions shall not include) any such creations, inventions or developments which demonstrably bear no relationship whatsoever to the business of the Company, or the application of technologies, ideas, or processes directly or indirectly related to the business of the Company. For the avoidance of doubt, the Company Inventions shall include any creations, inventions or developments that relate directly or indirectly to a Competitive Business. Executive further acknowledges that all original works of authorship which are created or contributed to by Executive (solely or jointly with others) within the scope of and during the period of Executive’s employment with the Company (“the Company Copyrights”) are to be deemed “works made for hire,” as that term is defined in the United States Copyright Act, and the copyright and all intellectual property rights therein shall be the sole property of the Company. To the extent any of such works are deemed not to be “works made for hire,” Executive hereby assigns the copyright and all other intellectual property rights in such works to the Company.
c. Contracts with the United States. Executive agrees to execute any licenses or assignments of the Company Inventions or the Company Copyrights as required by any contract between the Company and the United States or any of its agencies.
d.Further Assurances. Executive covenants to take all requested actions and execute all requested documents to assist the Company, or its designee, at the Company’s expense, in every way; consistent with applicable law, (1) to secure the Company’s above rights in the Company Inventions and any of the Company’s Copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, and (2) to pursue any patents or registrations with respect thereto. This covenant shall survive the termination of this Agreement. If the Company is unable for any reason, after reasonable efforts, to secure Executive’s signature on any document for this purpose, then Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s agent and attorney in fact, for the limited purpose of acting for and in Executive’s behalf and stead to execute such documents and to do all other lawfully permitted acts in connection with the execution of such documents.

e.Executive’s Rights Under Defend Trade Secrets Act.  Executive is hereby notified in accordance with the Defend Trade Secrets Act of 2016 that she will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Executive is further notified that if she files a lawsuit for retaliation by an employer for reporting a suspected violation of law, she may disclose the employer’s trade secrets to her attorney and use the trade secret information in the court proceeding if she: (x) files any document containing the trade secret under seal; and (y) does not disclose the trade secret, except pursuant to court order.
10.Specific Performance. Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened breach of any of the provisions of Sections 8 and 9 would be inadequate and, in recognition of this fact, Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available and in the event of a breach of Sections 8 and 9 shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement.
11.Miscellaneous.
a.Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of laws principles thereof.  The parties agree to litigate any claims or disputes between them or between Executive and any affiliate or employee of the Company, including any dispute arising under or related to this Agreement, Executive’s employment or termination of employment, Executive’s compensation or benefits, and any other dispute between the parties, exclusively in the state or federal courts located in the state of Executive’s primary place of business; provided, however, that the Company may initiate a lawsuit in another state to the extent the Company deems it necessary or desirable to enjoin a breach of this Agreement by Executive.  The parties hereby waive any objection to the personal jurisdiction or venue of the state and federal courts located in the state of Executive’s primary place of business or in any other state in which a lawsuit is initiated by the Company pursuant to the immediately preceding sentence, hereby submit to the personal jurisdiction and venue of such courts, and waive the defense of inconvenient forum and/or lack of personal jurisdiction.
b.Entire Agreement/Amendments. Except for the documents related to the Company and its affiliates’ equity incentive plans, this Agreement contains the entire understanding of the parties with respect to the employment of Executive by the Company, and there are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered, modified, or amended except by a written instrument signed by the parties hereto.
c.No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.
d.Severability. In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.

e.Assignment. This Agreement shall not be assignable by Executive. This Agreement may be assigned by the Company to a person or entity which is an affiliate or a successor in interest to substantially all of the business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such affiliate or successor person or entity.
f.No Mitigation, No Offset. Executive will not be required to mitigate the amount of any payment contemplated by Section 7, nor will any such payment be reduced by any earnings Executive may receive from any other source. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set- off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others. 
g.Successors; Binding Agreement. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
h.Notice. For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.
If to the Company:

One Washington Square
510-530 Walnut Street, Suite 1350
Philadelphia, PA 19106
Attention:  General Counsel
If to Executive:    
Executive’s address as reflected on the payroll records of the Company.
i. Executive Representation. Executive hereby represents to the Company that the execution and delivery of this Agreement by Executive and the Company and the performance by Executive of Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement or other agreement or policy to which Executive is a party or otherwise bound.
j. Cooperation. Following termination of Executive’s employment with the Company, Executive shall provide her reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder and the Company agrees that it shall promptly reimburse Executive for her reasonable and documented expenses in connection with her rendering assistance and/or cooperation under this Section 11(j) upon her presentation of documentation for such expenses. This provision shall survive any termination of this Agreement.
k.Withholding Taxes. The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation.
l.Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
m.Insurance. Notwithstanding anything to the contrary herein:
(i)All rights Executive has to indemnification as a director, officer or fiduciary pursuant to any agreement, applicable statue, Company bylaws or articles of organization as in effect from time to time shall not be impacted by the provisions of this Agreement and all such rights, if any, shall survive the termination and/or expiration of this Agreement and/or the termination of Executive’s employment with the Company; and
(ii)So long as Executive is employed by the Company, and for a period of six (6) years following Executive’s termination of employment, the Company agrees to purchase and maintain insurance for Executive’s benefit, covering director, officer and fiduciary liability on the same basis as active directors, officers and/or fiduciaries, as applicable, of the Company.
n.  Section 409A. The intent of the parties is that payments and benefits under this Agreement comply with or are exempt from Section 409A and this Agreement shall be interpreted and construed in a manner that establishes an exemption from (or compliance with) the requirements of Section 409A. Any terms of this Agreement that are undefined or ambiguous shall be interpreted in a manner that complies with Section 409A to the extent necessary to comply with Section 409A. Notwithstanding anything herein to the contrary, (i) if, on the date of termination, the Executive is a “specified employee” as defined in Section 409A, and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under Section 409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is the first business day of the seventh month following the date of termination (or the earliest date as is permitted under Section 409A), and (ii) if any other payments of money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under Section 409A, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Section 409A, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that preserves the economic benefit and original intent thereof but does not cause such an accelerated or additional tax. Notwithstanding anything to the contrary herein, to the extent required by Section 409A, a termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean separation from service. Notwithstanding anything to the contrary herein, except to the extent any expense, reimbursement or in-kind benefit provided pursuant to this Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A (1) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive in any other calendar year, (2) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, and (3) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit. Each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. Notwithstanding the foregoing, the Company does not make any representation to Executive that the payments or benefits provided under this Agreement are exempt from, or satisfy, the requirements of Section 409A, and the Company shall have no liability or other obligation to indemnify or hold harmless Executive or any beneficiary of Executive for any tax, additional tax, interest or penalties that Executive or any beneficiary of Executive may incur in the event that any provision of this Agreement, or any amendment or modification thereof, or any other action taken with respect thereto, is deemed to violate any of the requirements of Section 409A.

o.  Costs and Expenses. If any action or proceeding is brought by either party hereto seeking to collect any damages resulting from, or the injunction of any action constituting, a breach of any of the terms or provisions of this Agreement, then the non-prevailing party in the action or proceeding shall pay all reasonable costs and attorneys’ fees of the prevailing party.    

p.   No Drafting Party. The Executive acknowledges that she has had an opportunity to negotiate any and all of these provisions and no rule of construction shall be used that would interpret any provision in favor of or against a party on the basis of who drafted this Agreement.

q.    Jury Trial Waiver.  TO THE MAXIMUM EXTENT PERMITTED BY LAW, EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR EXECUTIVE’S EMPLOYMENT BY THE COMPANY.  

*****

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.

	
			
	 
	AGROFRESH SOLUTIONS, INC.

	 
	 

	 
	By:
	/s/ Nance K. Dicciani

	 
	 
	By: Nance K. Dicciani

	 
	 
	Title: Office of the Chair

	 
	 
	 

	 
	By:
	/s/ Katherine Harper

	 
	 
	By: Katherine Harper

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]